Hypertension in solid organ transplant recipients

Area of Science:

• Nephrology
• Cardiology
• Transplant Surgery

Background:

• Hypertension (HT) affects 70-90% of solid organ transplant recipients, posing a significant risk to patient and graft survival.
• The causes of post-transplant HT are multifactorial, varying by transplant type and time post-transplant.
• Key contributing factors include immunosuppressive medications (calcineurin inhibitors, steroids), impaired kidney function, and specific donor/recipient characteristics.

Purpose of the Study:

• To review the pathogenesis of hypertension following solid organ transplantation.
• To outline current treatment strategies for managing post-transplant hypertension.

Main Methods:

• This is a review article.
• Literature search on post-transplant hypertension pathogenesis and treatment.

Main Results:

• Early post-transplant HT is linked to volume expansion and increased systemic vascular resistance.
• Kidney transplant HT involves factors like donor age, renal artery stenosis, and graft function.
• Liver and heart transplant HT often relates to kidney dysfunction and immunosuppression.

Conclusions:

• Post-transplant hypertension is a critical complication requiring comprehensive management.
• Treatment involves both non-pharmacological and pharmacological approaches tailored to individual patient needs.